Similar Articles |
|
The Motley Fool January 31, 2006 Stephen D. Simpson |
Zimmer Muddles Through So long as the pressures in the orthopedic sector prove less than originally feared, investors could still make money here. |
The Motley Fool February 1, 2005 Stephen D. Simpson |
Zimmer Shoots From the Hip Pure-play orthopedic company delivers the goods, but at what cost? Zimmer carries a price tag that would make a value investor's bones ache. |
The Motley Fool January 27, 2006 Rich Smith |
Foolish Forecast: Boning Up on Zimmer With its margins as high as they are, and rising as steadily as they are, you won't be surprised to hear that the medical technology company's shares command premium prices. |
The Motley Fool July 23, 2009 Robert Steyer |
Long Convalescence for Device Makers Orthopedic product specialists Stryker and Zimmer Holdings forecast a slow-motion recovery. |
The Motley Fool July 26, 2007 Ryan Fuhrmann |
Zimmer Simmers The maker of hip and knee replacements gets a leg up on the market. Investors, take note. |
The Motley Fool January 30, 2007 Ryan Fuhrmann |
Zimmer Implants a New High Investors, the orthopedic designer, developer, and manufacturer isn't cheap, but stellar companies rarely are. |
The Motley Fool July 27, 2006 Stephen D. Simpson |
Zimmer Provides Quarterly Information, and More In addition to its quarterly review, the orthopedic company gave some insight into the government probe. Investors, take note. |
The Motley Fool April 27, 2006 Stephen D. Simpson |
Guidance Brings Zimmer to Its Knees Sales were a little light this quarter, and the company will have to hustle to meet full-year projections. Investors, tread carefully and only buy when there is a fitting margin of safety here. |
The Motley Fool October 25, 2007 Billy Fisher |
Plenty of Strength in Zimmer Orthopedic manufacturer Zimmer Holdings reports a solid third quarter, but lowers its forecast for Q4. |
The Motley Fool March 22, 2005 Stephen D. Simpson |
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. |
The Motley Fool January 27, 2006 Stephen D. Simpson |
Lightning Stryker The dust hasn't yet settled on the orthopedic sector, so wise investors should tread lightly with this medical technology company. |
The Motley Fool March 23, 2004 Glen Trematore |
Stryker's a Warrior Need a new hip or a new addition to your portfolio? Consider Stryker. |
The Motley Fool October 17, 2008 Brian Orelli |
Shareholders Slap Stryker A little earnings miss sends the medical technology company down more than necessary. |
The Motley Fool September 5, 2008 Brian Orelli |
Zimmer Fortifies Its Spine The medical-device maker is buying Abbott's spine business. |
The Motley Fool April 26, 2007 Ryan Fuhrmann |
Zimmer Holding Steady: Fool by Numbers The orthopedic designer, developer, and manufacturer released first-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool January 10, 2005 W.D. Crotty |
This "dj" is Primed to Play Hits Medical device company dj Orthopedics reaps huge gains after a good sales report. |
The Motley Fool October 18, 2007 Billy Fisher |
An Empire Strykes Back Stryker reports a quarter of double-digit growth in revenue and earnings. Investors, take note. |
The Motley Fool July 28, 2005 Stephen D. Simpson |
Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples. |
BusinessWeek May 30, 2005 Michael Arndt |
BW 50: A Test Of Zimmer's Agility Artificial joint maker Zimmer Holdings Inc. has the lead in a hot business. But the company faces a Justice probe and price pressures. |
The Motley Fool July 23, 2010 Jordan DiPietro |
Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider? |
The Motley Fool October 27, 2005 Stephen D. Simpson |
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. |
The Motley Fool April 30, 2004 W.D. Crotty |
Ingram Micro Flops The world's largest technology wholesaler, Ingram Micro, did a belly flop in the New York stock exchange pool today. |
The Motley Fool December 12, 2006 Matthew Crews |
Smith & Nephew, What's the Deal? A merger with Biomet would be good in many ways. But what's the right price? Investors, take note. |
The Motley Fool March 9, 2004 Rich Smith |
Interpore Gets Transplanted Will its acquisition by medical equipment maker Biomet pay off for Interpore's shareholders? |
The Motley Fool November 6, 2006 Matthew Crews |
Smith & Nephew Is Hip to Growth The medical technology company is showing solid growth, but a possible acquisition is cause for concern. Investors, take note. |
The Motley Fool July 21, 2006 Stephen D. Simpson |
Stryker and the Terror of the Unknown This has been a pretty bad year to be a good medical technology company. Fears about future pricing and the DOJ investigation keep a lid on the entire sector. So, what about that future for Stryker? Investors, take note. |
The Motley Fool April 27, 2007 Ryan Fuhrmann |
Hip Results at Zimmer Holdings The orthopedic-implant and surgical-product maker is impressing investors, and it may just be warming up. |
The Motley Fool April 16, 2004 Bill Mann |
Stryker Hits It Again Stryker, the medical device company, reported year-over-year gains in revenues of 22%, with sales just over $1 billion. Earnings were even better: Stryker topped off last year's results by more than 30%. |
The Motley Fool July 18, 2008 Brian Orelli |
What Strikes Against Stryker? High growth isn't enough to impress investors. |
The Motley Fool October 18, 2006 Matthew Crews |
Stryker Is Steady Eddy How long can Stryker maintain its Steady Eddy persona? Net earnings will decelerate when gross margins peak. |
The Motley Fool May 27, 2011 Andrew Tonner |
Does Zimmer Holdings Deserve a Spot in Your Portfolio? Compared to it's peers, Zimmer Holdings doesn't look like a stock for your portfolio right now. |
The Motley Fool February 27, 2004 Mark Mahorney |
Shuffle Master's No Shell Game Gaming equipment company Shuffle Master had a big week, announcing two acquisitions and reporting fiscal first-quarter earnings. |
The Motley Fool June 28, 2004 Rick Aristotle Munarriz |
Food for Fiscal Thought Food makers will open the cupboards this week to take stock of their quarterly earnings. |
IndustryWeek August 1, 2003 David Drickhamer |
Profit Power! Our top 50 U.S. manufacturers leverage operational prowess for superior profitability. |
The Motley Fool July 20, 2004 Rick Aristotle Munarriz |
Margins of Error Profit margins matter. It's why we can get more excited about a company with rich margins when it grows sales -- we know that much more of the incremental dollar will work its way down to the bottom line unscathed. |
The Motley Fool July 27, 2006 Stephen D. Simpson |
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. |
The Motley Fool September 21, 2005 Stephen D. Simpson |
Can Biomet Stay Limber? Concerns about pricing have buffeted the orthopedic space and the No. 4 player in hips and knees. Whatever the case turns out to be, Biomet is probably a bit riskier than average. |
The Motley Fool August 28, 2008 Brian Orelli |
Stryker Strikes Back The orthopedics maker sues to stop a costly federal investigation. |
The Motley Fool September 20, 2006 Ryan Fuhrmann |
Biomet's Aching Joints Biomet operates in the appealing medical device industry, but current growth trends are giving investors a headache. |
The Motley Fool January 28, 2009 Brian Orelli |
The Streak Is Over After 31 consecutive quarters of double-digit sales growth, medical device maker Stryker finally had an off quarter. |
The Motley Fool August 10, 2011 Evan Niu |
One Medical-Device Stock to Buy MAKO Surgical delivers strong results. |
The Motley Fool September 14, 2005 Stephen D. Simpson |
Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance. |
The Motley Fool April 26, 2005 Stephen D. Simpson |
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. |
The Motley Fool February 11, 2004 W.D. Crotty |
Health-Care Opportunity Health Net looks like a value-priced managed care company. |
The Motley Fool June 21, 2004 Seth Jayson |
Walgreen's Fine Follow-Up It's another solid quarter for America's soon-to-be No. 2 drugstore. |
The Motley Fool May 6, 2004 |
When There Are No Earnings You don't necessarily need earnings to evaluate a company. |
The Motley Fool March 28, 2006 Stephen D. Simpson |
A Surprising Turn at Biomet The large orthopedic company replaces one of its founders. This change doesn't really make the stock dramatically more, or less, attractive than before. Investors, take note. |
The Motley Fool January 28, 2011 Michael Olsen |
Rising Star Buy: Zimmer Holdings Current trends, coupled with an aging population, should provide consistent and growing demand for Zimmer's wares. |
The Motley Fool May 28, 2004 Roger Nusbaum |
Stryker Stands Out This is one medical equipment maker that looks good. |
The Motley Fool October 26, 2006 |
No Holding Back Zimmer: Fool by Numbers The maker of orthopedic implants released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |